Endogenous modulation of monoamine oxidase in schizophrenic and normal humans



	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted



	Email this article to a Colleague
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to My Articles & Searches
	Download to citation manager



	Citing Articles via HighWire
	Citing Articles via Google Scholar



	Articles by Becker, R. E.
	Articles by Giambalvo, C. T.
	Search for Related Content



	PubMed Citation
	Articles by Becker, R. E.
	Articles by Giambalvo, C. T.

Am J Psychiatry 1982; 139:1567-1570
Copyright © 1982 by American Psychiatric Association

REGULAR ARTICLES

Endogenous modulation of monoamine oxidase in schizophrenic and normal humans

RE Becker and CT Giambalvo

Plasma from normal subjects and chronic schizophrenic patients produced nearly equal inhibitory effects on platelet and bovine brain monoamine oxidase (MAO) activity. Plasma from controls and patients with high platelet MAO activity caused less decrease in platelet MAO kinetic variables (Km, Vmax) than plasma from subjects with midrange or low MAO activity. When bovine striatal MAO was used, with serotonin as substrate, plasma from schizophrenic patients caused less decrease in Vmax than plasma from controls. These inhibitory effects are associated with the presence in plasma of one or more nonalbumin proteins with low molecular weight.

This article has been cited by other articles:

R. Becker, C Giambalvo, R. Fox, and M Macho
Endogenous inhibitors of monoamine oxidase present in human cerebrospinal fluid
Science, July 29, 1983; 221(4609): 476 - 478.
[Abstract] [PDF]

Get information about faster international access.